Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Parkinson Disease”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Testing effectiveness (Phase 2)Study completedNCT00209508
What this trial is testing

2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD

Who this might be right for
Parkinson's Disease
Eisai Inc. 200
Post-approval studies (Phase 4)Study completedNCT02586623
What this trial is testing

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
H. Lundbeck A/S 453
Testing effectiveness (Phase 2)Study completedNCT06671938
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

Who this might be right for
Parkinson DiseaseMultiple System Atrophy
BioArctic AB 38
Large-scale testing (Phase 3)Study completedNCT00738062
What this trial is testing

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Neurogenic Orthostatic HypotensionNon-Diabetic Autonomic NeuropathyMultiple System Atrophy+1 more
Chelsea Therapeutics 103
Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Not applicableStudy completedNCT05388526
What this trial is testing

Frailty and Cognitive Function in Parkinson's Disease.

Who this might be right for
Parkinson Disease
University of Oviedo 100
Not applicableStudy completedNCT05480215
What this trial is testing

Symptomatic Relief of Action Tremor With Cala Trio Using Trio+ Bands

Who this might be right for
Essential TremorParkinson Disease
Cala Health, Inc. 20
Large-scale testing (Phase 3)Ended earlyNCT01927055
What this trial is testing

A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionParkinson's DiseaseMultiple Systems Atrophy+2 more
Chelsea Therapeutics 61
Large-scale testing (Phase 3)Study completedNCT00633880
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 181
Testing effectiveness (Phase 2)Active Not RecruitingNCT03775096
What this trial is testing

Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson DiseaseSymptomatic Parkinson Disease
Michele Tagliati, MD 15
Not applicableUnknownNCT02361255
What this trial is testing

Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism

Who this might be right for
Secondary ParkinsonismParkinson's Disease
Corporal Michael J. Crescenz VA Medical Center 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04386317
What this trial is testing

Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson's DiseaseSymptomatic Parkinson Disease
Cedars-Sinai Medical Center 15
Not applicableUnknownNCT04729010
What this trial is testing

Acupuncture for Anxiety in Parkinson's Disease

Who this might be right for
Parkinson DiseaseAnxiety
Xiamen University 30
Testing effectiveness (Phase 2)Study completedNCT05214287
What this trial is testing

Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease

Who this might be right for
Parkinson DiseaseEffect of Drug
Radboud University Medical Center 29
Not applicableUnknownNCT02275884
What this trial is testing

Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Technische Universität Dresden 30
Testing effectiveness (Phase 2)Study completedNCT02111122
What this trial is testing

Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease

Who this might be right for
Sleep-wake Disturbances in Motor-phase Parkinson's Disease
Christian Baumann 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05669170
What this trial is testing

Methylphenidate for Apathy in Veterans With Parkinson's Disease

Who this might be right for
Parkinson DiseaseApathy
Ralph H. Johnson VA Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT05931575
What this trial is testing

Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson´s Disease
Technical University of Munich 81
Large-scale testing (Phase 3)Study completedNCT03750552
What this trial is testing

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 195
Not applicableLooking for participantsNCT06920134
What this trial is testing

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Who this might be right for
Hypotension SymptomaticParkinson's DiseaseOrthostatic Hypotension, Dysautonomic+2 more
Ecole Polytechnique Fédérale de Lausanne 5
Next Page